Back to today’s briefing

Story perspectives

Repare Therapeutics Secures $4M Deal, Focuses on Trials

5/2/2025

43 8

Summary

Story summary

Repare Therapeutics has struck a $4 million deal with Canadian firm DCx Biotherapeutics, granting them access to its innovative discovery platforms and a 10% equity stake. DCx will hire 20 preclinical researchers and take over lab facilities in Montreal, allowing Repare to concentrate on its clinical portfolio while keeping a stake in its technologies. Exciting initial trial data is anticipated by late 2025.

1 of 1

Story summary

Repare Therapeutics has struck a $4 million deal with Canadian firm DCx Biotherapeutics, granting them access to its innovative discovery platforms and a 10% equity stake. DCx will hire 20 preclinical researchers and take over lab facilities in Montreal, allowing Repare to concentrate on its clinical portfolio while keeping a stake in its technologies. Exciting initial trial data is anticipated by late 2025.